Search results: Sage Journals

Restricted accessCase reportFirst published October, 2020

Sacubitril/Valsartan (Entresto®)-Induced Hyponatremia

Ilana Fuzaylova, Chester Lam, Om Talreja [...]

Journal of Pharmacy Practice

Restricted accessResearch articleFirst published December, 2023

Dapagliflozin-entresto protected kidney from renal hypertension via downregulating cell-stress signaling and upregulating SIRT1/PGC-1α/Mfn2-medicated mitochondrial homeostasis

Sheung-Fat Ko, Chih-Chao Yang, Pei-Hsun Sung [...]

Experimental Biology and Medicine

Restricted accessCase reportFirst published April, 2025

In re Entresto

Christopher M. Holman

Biotechnology Law Report

Restricted accessResearch articleFirst published August, 2026

Drafting a Pharmaceutical Composition Claim Covering Later-Developed Combination Drugs Without Losing the Disclosure Requirement Challenge: In re Entresto,125 F.4th 1090 (Fed. Cir. 2025)

PING-HSUN CHEN

Biotechnology Law Report

Restricted accessReview articleFirst published June, 2016

A New Mechanism of Action in Heart Failure

Jonathan Richardson, Tosin David, Yasmin Grace [...]

Journal of Pharmacy Technology

Restricted accessReview articleFirst published April, 2025

In re Entresto and the Standard of Review for Compliance with the Written Description Requirement

Christopher M. Holman

Biotechnology Law Report

Open accessResearch articleFirst published 2024

Association Between Use of Sodium-Glucose Cotransporter-2 Inhibitors or Angiotensin Receptor-Neprilysin Inhibitor and the Risk of Atherosclerotic Cardiovascular Disease With Coexisting Diabetes and Heart Failure

Ya-Wen Lin, Chun-Hsiang Lin, Cheng-Li Lin [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Restricted accessResearch articleFirst published February, 2022

Patient Education and Sacubitril/Valsartan: A Randomized Comparative Trial

Christopher Giuliano, Bradley St. Pierre, Jamie George

Hospital Pharmacy

Restricted accessCase reportFirst published April, 2017

Potential Issues with New Basal Insulin/GLP-1 Fixed Combinations: Hydroxyzine-Hydroxyurea Mix-up: Concomitant Use of Entresto and ACE Inhibitors can Lead to Serious Outcomes: More Outpatient Oral Cancer Drugs should be in Blister Packs

Michael R. Cohen, Judy L. Smetzer

Hospital Pharmacy

Restricted accessCase reportFirst published April, 2017

Potential Issues with New Basal Insulin/GLP-1 Fixed Combinations: Hydroxyzine-Hydroxyurea Mix-up: Concomitant Use of Entresto and ACE Inhibitors can Lead to Serious Outcomes: More Outpatient Oral Cancer Drugs should be in Blister Packs

Michael R. Cohen, Judy L. Smetzer

Hospital Pharmacy

Restricted accessCase reportFirst published October, 2020

Sacubitril/Valsartan (Entresto®)-Induced Hyponatremia

Ilana Fuzaylova, Chester Lam, Om Talreja [...]

Journal of Pharmacy Practice

Restricted accessResearch articleFirst published December, 2023

Dapagliflozin-entresto protected kidney from renal hypertension via downregulating cell-stress signaling and upregulating SIRT1/PGC-1α/Mfn2-medicated mitochondrial homeostasis

Sheung-Fat Ko, Chih-Chao Yang, Pei-Hsun Sung [...]

Experimental Biology and Medicine

Restricted accessCase reportFirst published April, 2025

In re Entresto

Christopher M. Holman

Biotechnology Law Report

Restricted accessResearch articleFirst published August, 2026

Drafting a Pharmaceutical Composition Claim Covering Later-Developed Combination Drugs Without Losing the Disclosure Requirement Challenge: In re Entresto,125 F.4th 1090 (Fed. Cir. 2025)

PING-HSUN CHEN

Biotechnology Law Report

Restricted accessReview articleFirst published June, 2016

A New Mechanism of Action in Heart Failure

Jonathan Richardson, Tosin David, Yasmin Grace [...]

Journal of Pharmacy Technology

Restricted accessReview articleFirst published April, 2025

In re Entresto and the Standard of Review for Compliance with the Written Description Requirement

Christopher M. Holman

Biotechnology Law Report

Open accessResearch articleFirst published 2024

Association Between Use of Sodium-Glucose Cotransporter-2 Inhibitors or Angiotensin Receptor-Neprilysin Inhibitor and the Risk of Atherosclerotic Cardiovascular Disease With Coexisting Diabetes and Heart Failure

Ya-Wen Lin, Chun-Hsiang Lin, Cheng-Li Lin [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Restricted accessResearch articleFirst published February, 2022

Patient Education and Sacubitril/Valsartan: A Randomized Comparative Trial

Christopher Giuliano, Bradley St. Pierre, Jamie George

Hospital Pharmacy

Restricted accessCase reportFirst published April, 2017

Potential Issues with New Basal Insulin/GLP-1 Fixed Combinations: Hydroxyzine-Hydroxyurea Mix-up: Concomitant Use of Entresto and ACE Inhibitors can Lead to Serious Outcomes: More Outpatient Oral Cancer Drugs should be in Blister Packs

Michael R. Cohen, Judy L. Smetzer

Hospital Pharmacy

Restricted accessCase reportFirst published April, 2017

Potential Issues with New Basal Insulin/GLP-1 Fixed Combinations: Hydroxyzine-Hydroxyurea Mix-up: Concomitant Use of Entresto and ACE Inhibitors can Lead to Serious Outcomes: More Outpatient Oral Cancer Drugs should be in Blister Packs

Michael R. Cohen, Judy L. Smetzer

Hospital Pharmacy